In February 2020, the U.S. Food & Drug Administration (FDA) recalled the weight-loss drugs Belviq RX and Belviq (lorcaserin) because of an increased risk of users developing cancer.
As such, current lawsuits allege that the drugmaker misled the public for years by withholding safety concerns regarding a link between lorcaserin and cancer.
Please contact Mike Brandner Injury Attorney for a free no-obligation Belviq lawsuit consultation if you or a loved one took the prescription drug lorcaserin for at least six months collectively and later developed pancreatic, colorectal, or lung cancer.
You may qualify to take legal action against the drugmaker and seek compensation.
Who Is the Maker of Belviq?
Belviq and Belviq XR were initially manufactured and sold by Arena Pharmaceuticals. However, in 2017 Tokyo-based drugmaker Eisai Inc. acquired global commercialization rights to Belviq.
Belviq is a 10 milligram tablet intended to be taken twice a day. Alternatively, Belviq XR is the extended-release form of the drug and is only taken once a day.
How Does Belviq Work?
Belviq was designed to control specific serotonin receptors in the brain that affect appetite to trigger feelings of fullness and satisfaction. In other words, the drug alters the chemical balance in a patient’s brain to trick their body into believing it is no longer hungry.
When Was Belviq First Approved for Consumer Use?
This weight-management supplement was first approved by the FDA for U.S. consumer use back in 2012 as a new medication that targeted long-term weight control. Just four years later the FDA approved Belviq XR.
Belviq was designed to be part of a life-long therapy to assist patients found to be obese (BMI 30 or greater) or overweight (BMI 27 or greater). When used in conjunction with exercise and a balanced diet, obese and overweight patients 18 years of age or older were more successful in reaching and staying at a healthy weight.
In turn, other weight-related health conditions could also be treated, such as high blood pressure, high cholesterol, hyperlipidemia, and type 2 diabetes.
After the drugs were released into the market, the FDA required the drugmaker to conduct a long-term trial to outrule potential cardiovascular concerns in patients taking the drug. Upon completion of reviewing the data collected for the cardiovascular trial, the FDA noted that 7.7 percent of patients treated with lorcaserin had developed cancer in comparison to 7.1 percent of those in the placebo group.
What Types of Cancers Are Linked to Belviq/Belviq XR?
In addition to a list of potentially dangerous side-effects that patients may experience after taking lorcaserin, the FDA found a potential increased risk for patients who have taken Belviq or Belviq RX developing cancer.
The three most prevalent types of cancers linked to the use of lorcaserin include:
- colorectal cancer
- lung cancer
- pancreatic cancer
Brain cancer, breast cancer, and other types of cancer are also being evaluated in patients who took Belviq or Belviq XR.
Because of these potentially life-altering health risks linked to Belviq and Belviq RX, the FDA called for the drug to be removed from the U.S. market on February 13, 2020.
“The U.S. Food and Drug Administration (FDA) has requested that the manufacturer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market because a safety clinical trial shows an increased occurrence of cancer. The drug manufacturer, Eisai Inc,. has submitted a request to voluntarily withdraw the drug.”
Belviq Lawsuit Inquiries
Did you or a loved one develop colorectal cancer, lung cancer, or pancreatic cancer after taking Belviq/Belviq RX? Then you may be eligible to join a Belviq cancer lawsuit against the drugmaker responsible for producing and marketing this drug.
If you qualify, you may be entitled to compensation for:
- Medical costs
- Pain and suffering
- Lost wages
- Loss of earning capacities
- Loss of enjoyment and quality of life
- Funeral expenses after wrongful death
- Other damages
How to Get a Free Consultation with a Belviq Cancer Lawyer
Contact Mike Brandner Injury Attorneys today for a free consultation to learn more about your legal options regarding a potential Belviq lawsuit. Our lawyers are experienced in navigating the complex legal system and are dedicated to ensuring your success in filing a Belviq cancer lawsuit.
Connect with us 24/7 through our convenient online LiveChat feature or by sharing more details about your health history through a form. You can also give us a call at 504-345-1111 day or night, or stop by our office Monday – Friday, from 8:00 a.m. to 5:00 p.m.